CD44 standard form expression is correlated with high-grade and advanced-stage ovarian carcinoma but not prognosis. - Wikidata - awgldk - TriplyDB

CD44 standard form expression is correlated with high-grade and advanced-stage ovarian carcinoma but not prognosis.

CD44 standard form expression is correlated with high-grade and advanced-stage ovarian carcinoma but not prognosis.

http://www.wikidata.org/entity/Q37118119

about

Meta-Analysis of Prognostic and Clinical Significance of CD44v6 in Esophageal Cancer CD44v/CD44s expression patterns are associated with the survival of pancreatic carcinoma patients Simultaneous targeting of CD44 and EpCAM with a bispecific aptamer effectively inhibits intraperitoneal ovarian cancer growth.New evidence guiding extent of lymphadenectomy for esophagogastric junction tumor: Application of Ber-Ep4 Joint with CD44v6 staining on the detection of lower mediastinal lymph node micrometastasis and survival analysis.Concurrent CD44s and STAT3 expression in human clear cell renal cellular carcinoma and its impact on survival Expression and significance of CD44, CD47 and c-met in ovarian clear cell carcinoma Expression of Stem Cell Markers in Preinvasive Tubal Lesions of Ovarian Carcinoma.Expression and Function of CD44 in Epithelial Ovarian Carcinoma The prognostic role of the cancer stem cell marker CD44 in ovarian cancer: a meta-analysis.Targeting hyaluronic acid family for cancer chemoprevention and therapy.The prognostic value and clinicopathological significance of CD44 expression in ovarian cancer: a meta-analysis.Surface markers of cancer stem-like cells of ovarian cancer and their clinical relevance.Co-expression and prognostic significance of the HER family members, EGFRvIII, c-MET, CD44 in patients with ovarian cancer.

P2860

Q26801136-9F9E31C8-FE72-4582-A22E-747063FE609B Q30584751-99D280AC-8F17-4E42-8122-D33696E61C59 Q33588273-2B392F66-658A-42CC-A7A8-81C6BBAAC101 Q33621299-0E8F54F9-004D-43BC-9C68-FC4F64EA6000 Q33898664-78294412-E1E6-4CAA-92F3-945B49AC2D49 Q35139055-06FB6A76-E02B-4ABC-8FCE-FC9537248083 Q36172983-2D8BB8D3-20D0-466D-8349-DD49E4744624 Q36409587-A6949AC3-F42C-4320-B990-1AADA192E15F Q37564029-9275B5AE-F11C-44BA-A16C-BFAFD2AA35C5 Q38235792-ACDAED0F-83DF-414E-A1DE-81BD36A2C55B Q51703765-0967E687-2BAC-4B62-A827-463CD68CEE51 Q53697399-BBD70663-7D96-492A-8657-B9D5CE99A9B2 Q54979642-F249475B-3DF9-4B7B-9F58-DD52686190EB

P2860

CD44 standard form expression is correlated with high-grade and advanced-stage ovarian carcinoma but not prognosis.

http://www.wikidata.org/entity/Q37118119

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 07 May 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

CD44 standard form expression ...... n carcinoma but not prognosis.

@en

CD44 standard form expression ...... n carcinoma but not prognosis.

@nl

type

label

CD44 standard form expression ...... n carcinoma but not prognosis.

@en

CD44 standard form expression ...... n carcinoma but not prognosis.

@nl

prefLabel

CD44 standard form expression ...... n carcinoma but not prognosis.

@en

CD44 standard form expression ...... n carcinoma but not prognosis.

@nl

P1433

Q37118119-551DADC7-2674-4B1B-8E60-7941A846674B

P1476

Q37118119-ED9AED6D-2B55-471E-A13F-59D26FA75C07

P2093

Q37118119-8E532ED7-A48B-4B71-97B4-84BFF5A6022A

Q37118119-9558F48B-1708-4B9D-8384-C1F0F3F6492F

Q37118119-A181C230-5866-4579-B3DF-DD426D17F686

P2860

Q37118119-08F27A5D-333B-488D-B75E-A5DABB656232

Q37118119-10679C68-F4E5-48EC-A9ED-C420F1E6785E

Q37118119-21F9A1A5-0523-4495-A923-6166AC242B07

Q37118119-323C1369-862E-4CFD-81D7-7ABC2935DA47

Q37118119-436AF8A8-2484-4899-B2C8-731561191B0F

Q37118119-4535BB9B-C51D-4504-BED4-5E1ECF4A6CC1

Q37118119-4743EEB9-7AB6-4488-BFEB-F3D78739D888

Q37118119-541400AD-B9DF-4633-A36D-BB05B738629A

Q37118119-6605EAB9-8421-471D-949B-8A6795C40489

Q37118119-7AA4FA7A-7F5C-4502-9AEE-35A69BD81387

P304

Q37118119-EC8EED5E-593E-43B2-A9B3-16FB212326C6

P31

Q37118119-71DB205C-4312-4A36-A8DF-55F630D3F5C7

P356

Q37118119-9455045A-5C5A-4D82-B793-17E887FBD4DD

P407

Q37118119-1F6BBFBC-25F5-4FBC-AAF6-694A8FD9EB57

P433

Q37118119-87E2177D-3A3E-40C9-8627-05D3216343AC

P478

Q37118119-FBBBB8C8-5DAC-4096-9997-6D614001E8A8

P577

Q37118119-841A53C2-5181-4A8E-A911-D36999187980

P698

Q37118119-05C670B3-72A4-4726-B131-4B0712935788

P932

Q37118119-F5911554-B515-44A5-91B7-3C76DE3CBD03

P356

J.HUMPATH.2013.02.016

P1433

Human Pathology

P1476

CD44 standard form expression ...... n carcinoma but not prognosis.

@en

P2093

Bin Chang

http://www.w3.org/2001/XMLSchema#string

Jing Zhang

http://www.w3.org/2001/XMLSchema#string

Jinsong Liu

http://www.w3.org/2001/XMLSchema#string

P2860

CD44 expression indicates favorable prognosis in epithelial ovarian cancer

Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells

The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation

Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer.

CD44 and beta1 integrin mediate ovarian carcinoma cell adhesion to peritoneal mesothelial cells.

CD44 in cancer progression: adhesion, migration and growth regulation.

Cell-matrix interaction via CD44 is independently regulated by different metalloproteinases activated in response to extracellular Ca(2+) influx and PKC activation.

Evidence for cancer stem cells contributing to the pathogenesis of ovarian cancer.

Expression of CD44S and CD44v5 is more common in stage III than in stage I serous ovarian carcinomas.

Identification of cancer stem cell-like cells from human epithelial ovarian carcinoma cell line.

P304

1882-1889

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.HUMPATH.2013.02.016

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

44

http://www.w3.org/2001/XMLSchema#string

P577

2013-05-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23664487

http://www.w3.org/2001/XMLSchema#string

P932

3752324

http://www.w3.org/2001/XMLSchema#string